Other
Hearing tests
Hearing tests is an intervention with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
OTHER
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
1
33%
Ph phase_4
1
33%
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution2 total trials
Phase 4Post-market surveillance
1(50.0%)
N/ANon-phased studies
1(50.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Active(1)
Completed(1)
Other(1)
Detailed Status
unknown1
Completed1
Not yet recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 41 (50.0%)
N/A1 (50.0%)
Trials by Status
unknown133%
completed133%
not_yet_recruiting133%
Recent Activity
0 active trials
Showing 3 of 3
completed
Investigation of the Impact of Medications Used in COVID-19 Treatment and COVID-19 Vaccine on Hearing
NCT07254442
not_yet_recruitingnot_applicable
Exploring the Links Between Hearing, Cognition and Brain Activity in People With Tinnitus
NCT06940726
unknownphase_4
Lidoderm Patch (Lidocaine 5%) for Tinnitus Treatment
NCT02750969
Clinical Trials (3)
Showing 3 of 3 trials
NCT07254442
Investigation of the Impact of Medications Used in COVID-19 Treatment and COVID-19 Vaccine on Hearing
NCT06940726Not Applicable
Exploring the Links Between Hearing, Cognition and Brain Activity in People With Tinnitus
NCT02750969Phase 4
Lidoderm Patch (Lidocaine 5%) for Tinnitus Treatment
All 3 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 3